LAUREN ARMSTRONG: Open Payments
NPI 1215578752 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,974 in 98 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $88 · 2025 $1,974
Food & beverage: $1,974
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 21 | $438 |
| ABBVIE INC. | 19 | $352 |
| Paratek Pharmaceuticals, Inc. | 16 | $339 |
| ViiV Healthcare Company | 20 | $329 |
| Merck Sharp & Dohme LLC | 7 | $160 |
| Theratechnologies Inc. | 6 | $144 |
| La Jolla Pharmaceutical Company | 4 | $92 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Insmed, Inc. | 2 | $39 |
| Teleflex LLC | 1 | $38 |
Products named: NUZYRA, DOVATO, AVYCAZ, Biktarvy, PIFELTRO, EGRIFTA, CABENUVA, ZEVTERA.
Industry payments across MS — which companies pay providers there.
